SCOR SE Act. Prov. Regpt.

SCR: XPAR (FRA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
%%LOCK|??vLOCK|Mdjv^Wb

Scor Earnings: Some Lingering Effects in Life and Health Spook the Market

Scor has delivered a pretty decent set of results for the second quarter of 2025, beating company-compiled consensus in some key areas. However, we think the market is probably focused on some residual life and health negative experience variance.

Sponsor Center